Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial

Obes Surg. 2013 Aug;23(8):1252-61. doi: 10.1007/s11695-013-0894-2.

Abstract

Background: Due to the association between the quantity of adipose tissue and concentrations of interleukin-6 (IL-6) and tumor necrosis factor (TNF-α), this work aimed to assess the effects of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) procedures on serum IL-6 and TNF-α concentrations.

Methods: This study evaluated serum IL-6 and TNF-α levels, as well as routine anthropometric and biochemical values, before and 1 year post-bariatric surgery. Fifty percent of patients (n = 24) underwent RYGB, and 50 % (n = 24) underwent SG. Prior to bariatric surgery, IL-6 and TNF-α mRNA expression levels in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) were investigated in obese women.

Results: There was a significant reduction (p < 0.05) in all anthropometric and routine biochemical measurements in patients in the RYGB and SG groups 1 year post-surgery. The serum concentrations of IL-6 and TNF-α were reduced following surgery in both groups (p < 0.05). No differences in the relative expression levels of IL-6 and TNF-α were found between SAT and VAT prior to bariatric surgery.

Conclusions: RYGB and SG procedures demonstrated a similar impact on adipokine levels in women 1 year post-surgery. Both techniques may improve the course of chronic diseases and the state of inflammation associated with obesity.

MeSH terms

  • Adult
  • Body Mass Index
  • Brazil / epidemiology
  • Female
  • Gastric Bypass*
  • Gastroplasty*
  • Gene Expression Regulation
  • Humans
  • Inflammation / metabolism
  • Interleukin-6 / metabolism*
  • Obesity, Morbid / metabolism*
  • Obesity, Morbid / surgery*
  • Postoperative Period
  • Prospective Studies
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / metabolism*
  • Weight Loss

Substances

  • Interleukin-6
  • Tumor Necrosis Factor-alpha